Page 81 - Diamicron MR MIG Cycle 2(20-21) Final

10 di ab e t es re s e ar ch and c lin i c a l p ra ct ic e 16 3 (20 20) 1 0815 4

vier; Advisory Board fees from Sanofi-Aventis, Astra Zeneca, from India and Malaysia treated with sitagliptin or a
Boehringer Ingelheim, Novo Nordisk, Ely Lilly, and Novartis. sulfonylurea during Ramadan: A randomized, pragmatic
Fatheya Al Awadi, Javed Akram, Saud Al Sifri and Md Faridud- study. Curr Med Res Opin 2012;28:1289–96.
[11] Glimepiride in Ramadan Study Group. The efficacy and safety
din declare no conflicts of interest.
of glimepiride in the management of type 2 diabetes in
Muslim patients during Ramadan. Diabetes Care
Appendix A. Supplementary material 2005;28:421–2.
[12] Hassanein M, Abdallah K, Schweizer A. A double-blind,
Supplementary data to this article can be found online at randomized trial, including frequent patient-physician
https://doi.org/10.1016/j.diabres.2020.108154. contacts and Ramadan-focused advice, assessing vildagliptin
and gliclazide in patients with type 2 diabetes fasting during
Ramadan: The STEADFAST study. Vasc Health Risk Manag
2014;10:319–26.
RE FERE NCE S [13] Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J,
Kempler P, Kvapil M, et al. GUIDE study: Double-blind
comparison of once-daily gliclazide MR and glimepiride in
type 2 diabetic patients. Eur J Clin Invest 2004;34:
[1] International Diabetes Federation. IDF diabetes atlas – 9th
ed.; 2019. https://www.diabetesatlas.org/en/ [accessed 03 Dec 535–42.
2019]. [14] American Diabetes Association. 2. Classification and
[2] Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, diagnosis of diabetes: standards of medical care in diabetes-
Voinet C, et al. A population-based study of diabetes and its 2019. Diabetes Care 2019;42:S13–28.
characteristics during the fasting month of Ramadan in 13 [15] Zargar AH, Siraj M, Jawa AA, Hasan M, Mahtab H.
countries: Results of the epidemiology of diabetes and Maintenance of glycaemic control with the evening
Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care administration of a long acting sulphonylurea in male type 2
2004;27:2306–11. diabetic patients undertaking the Ramadan fast. Int J Clin
[3] Pew Research Center. The changing global religious Pract 2010;64:1090–4.
landscape; 2017. https://www.pewforum.org/wp-content/ [16] Kalra S, Aamir AH, Raza A, Das AK, Azad Khan AK, Shrestha
uploads/sites/7/2017/04/FULL-REPORT-WITH-APPENDIXES- D, et al. Place of sulfonylureas in the management of type 2
A-AND-B-APRIL-3.pdf [accessed 04 Dec 2019]. diabetes mellitus in South Asia: A consensus statement.
[4] Lee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Type 2 diabetes Indian J Endocrinol Metab 2015;19:577–96.
patient’s perspective on Ramadan fasting: A qualitative [17] Gribble FM, Ashcroft FM. Differential sensitivity of beta-cell
study. BMJ Open Diabetes Res Care 2017;5:e000365. and extrapancreatic K ATP channels to gliclazide. Diabetologia
[5] Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez 1999;42:845–8.
S, et al. Recommendations for management of diabetes [18] Ghouri N, Gatrad R, Sattar N, Dhami S, Sheikh A. Summer-
during Ramadan: Update 2010. Diabetes Care winter switching of the Ramadan fasts in people with
2010;33:1895–902. diabetes living in temperate regions. Diabet Med
[6] Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, 2012;29:696–7.
Al-Madani A, et al. Diabetes and Ramadan: practical [19] Hassanein M, Echtay A, Hassoun A, Alarouj M, Afandi B,
guidelines. Diabetes Res Clin Pract 2017;126:303–16. Poladian R, et al. Tolerability of canagliflozin in patients with
[7] Al Sifri S, Basiounny A, Echtay A, Al Omari M, Harman- type 2 diabetes mellitus fasting during Ramadan: Results of
Boehm I, Kaddaha G, et al. The incidence of hypoglycaemia in the Canagliflozin in Ramadan Tolerance Observational Study
Muslim patients with type 2 diabetes treated with sitagliptin (CRATOS). Int J Clin Pract 2017;71.
or a sulphonylurea during Ramadan: A randomised trial. Int J [20] Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous
Clin Pract 2011;65:1132–40. 3rd AG, et al. Flipping the metabolic switch: Understanding
[8] Al-Arouj M, Hassoun AA, Medlej R, Pathan MF, Shaltout I, and applying the health benefits of fasting. Obesity (Silver
Chawla MS, et al. The effect of vildagliptin relative to Spring) 2018;26:254–68.
sulphonylureas in Muslim patients with type 2 diabetes [21] Cho Y, Hong N, Kim KW, Cho SJ, Lee M, Lee YH, et al. The
fasting during Ramadan: The VIRTUE study. Int J Clin Pract effectiveness of intermittent fasting to reduce body mass
2013;67:957–63. index and glucose metabolism: A systematic review and
[9] Aravind SR, Al Tayeb K, Ismail SB, Shehadeh N, Kaddaha G, meta-analysis. J Clin Med 2019;8.
Liu R, et al. Hypoglycaemia in sulphonylurea-treated subjects [22] Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson
with type 2 diabetes undergoing Ramadan fasting: A five- CM. Early time-restricted feeding improves insulin
country observational study. Curr Med Res Opin sensitivity, blood pressure, and oxidative stress even without
2011;27:1237–42. weight loss in men with prediabetes. Cell Metab 2018;27.
[10] Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, 1212–1221 e3.
Loh SM, et al. Hypoglycemia in patients with type 2 diabetes